B, B., AF, S., D, R., SM, H., S, C. B., P, P., . . . J, K. (2023). Pharmacological impact of microRNAs in head and neck squamous cell carcinoma: Prevailing insights on molecular pathways, diagnosis, and nanomedicine treatment. Frontiers in pharmacology, 14, 1174330. https://doi.org/10.3389/fphar.2023.1174330
Chicago Style (17th ed.) CitationB, Bhattacharjee, Syeda AF, Rynjah D, Hussain SM, Chandra Bora S, Pegu P, Sahu RK, and Khan J. "Pharmacological Impact of MicroRNAs in Head and Neck Squamous Cell Carcinoma: Prevailing Insights on Molecular Pathways, Diagnosis, and Nanomedicine Treatment." Frontiers in Pharmacology 14 (2023): 1174330. https://doi.org/10.3389/fphar.2023.1174330.
MLA (9th ed.) CitationB, Bhattacharjee, et al. "Pharmacological Impact of MicroRNAs in Head and Neck Squamous Cell Carcinoma: Prevailing Insights on Molecular Pathways, Diagnosis, and Nanomedicine Treatment." Frontiers in Pharmacology, vol. 14, 2023, p. 1174330, https://doi.org/10.3389/fphar.2023.1174330.